Study on Cardiometabolic Risk in Adults with Obesity Identifying Genetic, Laboratory, and Clinical Factors

What this Trial Is About

Researchers are investigating cardiometabolic risk factors in people with obesity by studying genetic, clinical, and laboratory aspects. This observational study focuses on understanding how these factors contribute to cardiovascular risk in obese individuals. Participants are selected based on specific criteria including age and health status to better identify the underlying determinants of cardiometabolic risk. Participants will provide an additional blood sample during a dietetic visit for genetic and laboratory testing. Within one month of this visit, they will undergo a special non-invasive examination to assess vascular aging and artery health. This study does not involve any experimental treatments but collects detailed biological and clinical data to explore cardiometabolic risks. During the study, participants will have blood collected for genetic analyses, including gene sequencing and protein assays. They will also undergo vascular assessments to measure artery condition. Researchers will monitor various biomarkers such as miRNAs, insulinemia, C-peptide, and thyrotropin levels at baseline. The study is designed to gather comprehensive information about cardiovascular risk factors in obesity without affecting usual care.

Cardiometabolic Risk of Obese Subjects: Cross-sectional Study